ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,778Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 18

$503K Total Retail Price of All Prescriptions

Rank: 4 out of 18

389 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nevada
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 389 patients filled at least one prescription for a schedule two drug, compared to an average of 12%.

Schedule Three
Controlled Substances

15% of this provider’s 389 patients filled at least one prescription for a schedule three drug, compared to an average of 16%.

Risky Drugs to Seniors

2% of this provider’s 12,249 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$37 was the average price of a prescription from this provider, compared to $44 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LISINOPRIL 598 548 1 1
FUROSEMIDE 551 519 2 4
LEVOTHYROXINE SODIUM 521 487 3 2
WARFARIN SODIUM 460 411 4 9
OMEPRAZOLE 364 351 5 6
SIMVASTATIN 338 278 6 5
DONEPEZIL HCL 338 315 6 14
AMLODIPINE BESYLATE 337 316 8 7
LOVASTATIN 336 306 9 13
POTASSIUM CHLORIDE 335 318 10 12
METOPROLOL TARTRATE 327 275 11 8
NAMENDA 299 288 12 18
GABAPENTIN 283 168 13 10
HYDROCODONE-ACETAMINOPHEN 264 229 S3 14 3
CITALOPRAM HBR 254 225 15 16
RISPERIDONE 238 184 16 15
METFORMIN HCL 204 153 17 11
RANITIDINE HCL 189 175 18 33
DIGOXIN 188 184 19 27
CARVEDILOL 176 165 20 26
JANTOVEN 168 168 21 19
MIRTAZAPINE 166 159 22 23
ATENOLOL 159 158 23 21
ALENDRONATE SODIUM 138 132 24 20
ALBUTEROL SULFATE 133 133 25 68
IPRATROPIUM BROMIDE 131 131 26 61
GLIPIZIDE 123 122 27 36
CLONIDINE HCL 122 113 28 51
LACTULOSE 120 114 29 60
METHADONE HCL 107 44 S2 30 76
TRAMADOL HCL 101 88 31 28
PLAVIX 98 90 32 48
ISOSORBIDE MONONITRATE ER 97 85 33 87
NOVOLOG FLEXPEN 95 83 34 56
CARBIDOPA-LEVODOPA 95 95 34 35
SERTRALINE HCL 88 85 36 32
GLYBURIDE 88 73 R 36 57
LEVETIRACETAM 87 79 38 69
HYDROCHLOROTHIAZIDE 83 64 39 22
PHENYTOIN SODIUM EXTENDED 81 41 40 106
LEVEMIR FLEXPEN 80 39 41 77
LEVOFLOXACIN 80 76 41 74
KLOR-CON M20 79 72 43 44
QUETIAPINE FUMARATE 79 68 43 45
TAMSULOSIN HCL 77 60 45 29
METOCLOPRAMIDE HCL 76 76 46 93
HYDRALAZINE HCL 76 69 46 54
LEVEMIR 75 57 48 109
METOPROLOL SUCCINATE 72 72 49 38
SODIUM CHLORIDE 72 69 49 66
KLOR-CON M10 68 63 51 88
LANTUS 67 55 52 49
MORPHINE SULFATE ER 66 58 S2 53 30
SPIRONOLACTONE 62 50 54 43
GEMFIBROZIL 62 39 54 64
FENTANYL 60 60 S2 56 70
DIVALPROEX SODIUM 58 33 57 24
ALLOPURINOL 57 57 58 53
ESCITALOPRAM OXALATE 55 55 59 100
EXELON 55 55 59 84
CIPROFLOXACIN HCL 55 54 59 62
OLANZAPINE 54 54 62 148
PAROXETINE HCL 54 51 62 52
MEROPENEM 53 53 64 84
LOSARTAN POTASSIUM 53 52 64 31
OXYCODONE-ACETAMINOPHEN 50 50 S2 66 39
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.